FASN and hepatocellular carcinoma: Che et al. [44] studied the changes in lipid metabolism-related indicators between normal liver and hepatocellular carcinoma samples with FASN inhibition and overexpression and showed that the genes involved in the biosynthesis of TG and FA were upregulated in FASN-inhibited hepatocellular carcinoma samples, but the gene expression data of FASN-inhibited normal liver tissues did not occur.